Families face uncertainty when they are told that their child has leukemia, lymphoma or a myelodysplastic syndrome (MDS). It is a time filled with new people and situations, worries and change.
It may help to learn that, because of new and better therapies, cancer survival rates for children have improved significantly during the last several decades. Physicians, nurses and researchers continue to search for the causes of childhood leukemia, lymphoma and MDS to develop better treatments, and to tailor therapies to decrease the toxic effects of therapy.
Thursday, January 14, 2010
Subscribe to:
Post Comments (Atom)






No comments:
Post a Comment
Children's Cancer Journal